Feil Family Brain & Mind Research Institute

You are here

-methyladenosine modification of hepatitis B virus RNA differentially regulates the viral life cycle.

Title-methyladenosine modification of hepatitis B virus RNA differentially regulates the viral life cycle.
Publication TypeJournal Article
Year of Publication2018
AuthorsImam H, Khan M, Gokhale NS, McIntyre ABR, Kim G-W, Jang JYoung, Kim S-J, Mason CE, Horner SM, Siddiqui A
JournalProc Natl Acad Sci U S A
Date Published2018 Aug 13
ISSN1091-6490
Abstract

-methyladenosine (mA) RNA methylation is the most abundant epitranscriptomic modification of eukaryotic messenger RNAs (mRNAs). Previous reports have found mA on both cellular and viral transcripts and defined its role in regulating numerous biological processes, including viral infection. Here, we show that mA and its associated machinery regulate the life cycle of hepatitis B virus (HBV). HBV is a DNA virus that completes its life cycle via an RNA intermediate, termed pregenomic RNA (pgRNA). Silencing of enzymes that catalyze the addition of mA to RNA resulted in increased HBV protein expression, but overall reduced reverse transcription of the pgRNA. We mapped the mA site in the HBV RNA and found that a conserved mA consensus motif situated within the epsilon stem loop structure, is the site for mA modification. The epsilon stem loop is located in the 3' terminus of all HBV mRNAs and at both the 5' and 3' termini of the pgRNA. Mutational analysis of the identified mA site in the 5' epsilon stem loop of pgRNA revealed that mA at this site is required for efficient reverse transcription of pgRNA, while mA methylation of the 3' epsilon stem loop results in destabilization of all HBV transcripts, suggesting that mA has dual regulatory function for HBV RNA. Overall, this study reveals molecular insights into how mA regulates HBV gene expression and reverse transcription, leading to an increased level of understanding of the HBV life cycle.

DOI10.1073/pnas.1808319115
Alternate JournalProc. Natl. Acad. Sci. U.S.A.
PubMed ID30104368
Grant ListR01 AI125416 / AI / NIAID NIH HHS / United States
R21 AI129851 / AI / NIAID NIH HHS / United States